CALCA and infection: SAX also significantly inhibited HIV-1 trans-infection in a dose-dependent manner (Figure 3A), but had lower potency than CGRP, with pIC50 values [95% confidence intervals (CIs)] of 8.9 [9.9–7.9] compared to 10.2 [10.9–9.4], respectively.